UPDATED May 20, 2022
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EPAYBottomline Technologies | US$56.99 | 0.7% | 48.0% | US$2.6b | US$56.10 | PS5.1x | E56.4% | n/a | Software | ||
AZPNAspen Technology | US$166.30 | 4.3% | 17.7% | US$11.1b | US$172.43 | PS40.8x | E12.6% | n/a | Software | ||
EXODExodus Movement | US$12.25 | 0% | n/a | US$309.2m | n/a | PS13.5x | n/a | n/a | Software | ||
EXDWExceed World | US$1.20 | 0% | 21.2% | US$39.2m | n/a | PS348.8x | n/a | n/a | Consumer Services | ||
FSMK1ST SUMMIT BANCORP of Johnstown | US$42.00 | 0% | n/a | US$92.2m | n/a | PS11.2x | n/a | 3.9% | Banks | ||
MBKLMBT Bancshares | US$25.75 | -2.8% | 10.8% | US$52.6m | n/a | PB1.2x | n/a | 3.9% | Banks | ||
AIFSAgent Information Software | US$2.15 | 0% | -0.5% | US$10.1m | n/a | PS7963x | n/a | 1.6% | Software | ||
FMFPFirst Community Financial | US$22.00 | 0% | n/a | US$62.1m | n/a | PB1.1x | n/a | 3.2% | Banks | ||
PVBKPacific Valley Bancorp | US$10.31 | 0% | -5.0% | US$41.5m | n/a | PS11x | n/a | n/a | Banks | ||
PPALPeoples Trust Company of St. Albans | US$55.00 | 0% | -43.3% | US$31.5m | n/a | PS14.4x | n/a | 1.7% | Banks | ||
WHLTChase Packaging | US$0.08 | -24.2% | -20.0% | US$5.0m | n/a | PB10.5x | n/a | n/a | Materials | ||
OPRAOpera | US$5.23 | -2.1% | -49.7% | US$602.2m | US$12.00 | PS2.2x | E127.8% | n/a | Software | ||
HLTHCue Health | US$5.12 | 1.8% | n/a | US$755.0m | US$9.88 | PS22x | S9.7% | n/a | Healthcare | ||
REPLReplimune Group | US$14.79 | -0.3% | -59.2% | US$725.7m | US$47.80 | PB1.8x | E16.4% | n/a | Pharmaceuticals & Biotech | ||
EVGOEVgo | US$9.15 | 4.2% | -18.4% | US$2.4b | US$13.89 | PS94x | E68.2% | n/a | Retail | ||
IHiHuman | US$2.46 | -14.0% | -75.8% | US$131.3m | US$4.10 | PB1.4x | S24.9% | n/a | Media | ||
GRPHGraphite Bio | US$2.28 | -12.3% | n/a | US$132.2m | US$13.00 | PS-1.7x | E-14.9% | n/a | Pharmaceuticals & Biotech | ||
FBRXForte Biosciences | US$1.10 | -6.8% | -97.1% | US$16.2m | n/a | n/a | n/a | n/a | Pharmaceuticals & Biotech | ||
QFIN360 DigiTech | US$13.86 | 5.1% | -48.6% | US$2.2b | US$25.34 | PS2.5x | E8.4% | 7.4% | Diversified Financials | ||
ANVSAnnovis Bio | US$9.15 | -2.9% | -84.8% | US$74.7m | US$31.50 | PB1.8x | E-18.9% | n/a | Pharmaceuticals & Biotech | ||
PASGPassage Bio | US$2.02 | 10.4% | -85.2% | US$109.7m | US$13.43 | n/a | E9.3% | n/a | Pharmaceuticals & Biotech | ||
VERVVerve Therapeutics | US$13.41 | -2.3% | n/a | US$652.5m | US$52.00 | PB2x | E-17.0% | n/a | Pharmaceuticals & Biotech | ||
NRGVEnergy Vault Holdings | US$11.74 | 11.2% | 21.9% | US$1.6b | US$16.75 | PS36.6x | E94.8% | n/a | Capital Goods | ||
TALSTalaris Therapeutics | US$7.37 | 17.9% | -44.4% | US$305.6m | US$22.50 | PB1.4x | E-14.4% | n/a | Pharmaceuticals & Biotech |